Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00781898
First received: October 24, 2008
Last updated: September 7, 2016
Last verified: September 2016